Successful BRAF/MEK inhibition in a patient with BRAF(V600E)-mutated extrapancreatic acinar cell carcinoma

Pancreatic acinar cell carcinoma (PAC) is a rare disease with a poor prognosis. Treatment options for metastatic PAC are limited and often follow chemotherapeutic regimens for pancreatic ductal adenocarcinoma. Although recurrent genomic alterations, such as BRAF fusions and defects in genes involved...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cold Spring Harb Mol Case Stud
Main Authors: Busch, Elena, Kreutzfeldt, Simon, Agaimy, Abbas, Mechtersheimer, Gunhild, Horak, Peter, Brors, Benedikt, Hutter, Barbara, Fröhlich, Martina, Uhrig, Sebastian, Mayer, Philipp, Schröck, Evelin, Stenzinger, Albrecht, Glimm, Hanno, Jäger, Dirk, Springfeld, Christoph, Fröhling, Stefan, Zschäbitz, Stefanie
Format: Artigo
Jezik:Inglês
Izdano: Cold Spring Harbor Laboratory Press 2020
Teme:
Research Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7476408/
https://ncbi.nlm.nih.gov/pubmed/32843432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/mcs.a005553
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki